Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Neuroendocrine Tumors 1Meningeal Neoplasms 1Gynecologic Cancer 1Digestive System Diseases 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Tumor Adult 1

Interventions

Bevacizumab 2trifluridine tipiracil drug combination 1gadolinium ethoxybenzyl DTPA 1gadobutrol 1encorafenib 1durvalumab 1Urine Specimen Collection 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Oxaliplatin 1Oviposition 1Nivolumab 1Levoleucovorin 1Leucovorin 1Irinotecan 1Immunotherapy 1IDRX-42 1Hydromorphone 1Fluorouracil 1Fentanyl 1Drug Therapy 1Drainage 1Dietary Supplements 1Colonoscopy 1Cetuximab 1Capecitabine 1Bupivacaine 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Diseases × gadobutrol × 1 year × Clear all
NCT02156739 2025-12-22

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

M.D. Anderson Cancer Center

Phase NA Active not recruiting
100 enrolled
Gastrointestinal

Digestive System Diseases, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡